Latest Industry Updates
From company milestones to industry breakthroughs, uncover the stories making waves and shaping the narrative in real time.
- Press Release
We’re delighted to announce that the recording for our COVID-19 webinar has been posted! About the...
- Press Release
Remote monitoring is mitigating the impact of SARS-CoV-2 on clinical trials, marking an acceleration in the...
- Featured Article
The use of direct source data capture in clinical research is on the rise, both during...
Source: Clinical Research News
- Featured Article
The clinical research industry has gone through an important transformation over the past 15 to 20...
Source: ACRP
- Press Release
King of Prussia, PA: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality...
- Featured Article
Poor quality data has the potential to destroy the validity of a clinical trial, wasting precious...
Source: Tufts Center for the Study of Drug Development
- Press Release
KING OF PRUSSIA, PA: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality...
- Featured Article
Participant safety is the clinical trial sector’s top priority – and striving to achieve this laudable...
Source: Applied Clinical Trials
- Press Release
KING OF PRUSSIA, PA– FDA and its stakeholders have an interest in assuring the integrity of...
- Featured Article
The latest version of the Good Clinical Practice (GCP) quality standard insists that sponsors implement a...
Source: Global Forum
- Press Release
“I KNOW ICH E6 (R2) COMPLIANCE INSISTS ON A RISK-BASED APPROACH TO RUNNING MY TRIALS, BUT...
- Featured Article
A risk-based approach to clinical research may include a central statistical assessment of data quality.
...Source: Sage Journals
- Press Release
RBQM and AI leader was shortlisted for its Time Similarity Test in the ‘Innovative Clinical Trial...
- Press Release
King of Prussia, PA – April 1st, 2025: CluePoints, provider of leading statistical and AI-driven software...
- Press Release
The Company, along with its Research and Development Teams, were shortlisted for continuing its mission of...
- Press Release
CluePoints Appoints Richard Young as Chief Strategy Officer King of Prussia, PA – October 28th, 2024:...
- Press Release
King of Prussia, PA – October 23rd, 2024: CluePoints, provider of leading statistical and AI-driven software...
- Press Release
CluePoints furthers its commitment to delivering innovative solutions that enhance clinical trial efficiency with this latest...
- Press Release
Site Profile & Oversight Tool (SPOT) and Intelligent Medical Coding (IMC) unveiled by RBQM innovator at...
- Press Release
CluePoints is a cloud-based software platform for Risk-Based Quality Management (“RBQM”) and data quality oversight in...
- Press Release
KING OF PRUSSIA, Pa., — CluePoints, provider of leading statistical and AI-driven software solutions, today unveiled...
- Press Release
King of Prussia, PA: CluePoints, providers of leading statistical and AI-driven software solutions and Food and...
- Press Release
King of Prussia, PA – March 25, 2024: CluePoints, providers of best-in-class statistical and AI-driven software...
- Press Release
King of Prussia, PA: A comprehensive assessment of risk-based quality management (RBQM) adoption has revealed that...
- Featured Article
A conversation with Steve Young, member of Avoca Quality Consortium, PHUSE Working Group participant, and Tufts...
Source: Clinical Leader
- Featured Article
The pharmaceutical industry has a problem – a failure to provide women with C-suite opportunities.
...Source: International Clinical Trials
- Featured Article
The ICH E6(R3) draft guideline document, currently open to public consultation, places the industry firmly in...
Source: Applied Clinical Trials
- Featured Article
Despite the push for greater use of risk-based quality management (RBQM) in clinical research, adoption of...
Source: CenterWatch
- Featured Article
Central monitoring aims to detect emerging quality-related risks proactively during a clinical trial, resulting in study...
Source: Applied Clinical Trials
- Featured Article
Using key risk indicators (KRIs) can improve clinical trial data quality in 80% of the sites...
Source: Applied Clinical Trials
- Featured Article
Since the release of ICH E6(R2), multiple efforts have been made to interpret the requirements and...
- Read
Source: Springer Link
- Featured Article
An expectation for the use of quality tolerance limits (QTLs) was formally established in the International...
Source: Applied Clinical Trials
- Featured Article
Clinical research is evolving rapidly, with the digitalization of trials creating a new modus operandi and...
Source: Applied Clinical Trials
- Featured Article
Risk-based approaches to monitoring clinical trials were brought to the forefront with an FDA guidance published...
Source: Applied Clinical Trials
- Featured Article
Key risk indicators (KRIs) are metrics designed to identify risks of specific interest to study teams...
Source: Applied Clinical Trials
- Featured Article
The success of clinical development programmes, drug approval and marketing depends ultimately on the readability and...
Source: International Clinical Trials
